Epidemiology and Survival of Malignant Central Airway Obstruction in Lung Cancer Identified on Cross-Sectional Imaging
Authors:
- Nathaniel M. IvanickNINathaniel M. Ivanick
- Rajesh KunadharajuRKRajesh Kunadharaju
- Sajeer BhuraSBSajeer Bhura
- Hiwot MengisteHMHiwot Mengiste
- Musa SaeedMSMusa Saeed
- Harshwant GroverHGHarshwant Grover
- Sukumar KalvapudiSKSukumar Kalvapudi
- Sai YendamuriSYSai Yendamuri
- Han YuHYHan Yu
- Gal Dsc ShafirsteinGSGal Dsc Shafirstein
- Mary ReidMRMary Reid
Open Access
- 17 June 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Bronchology & Interventional Pulmonology
- Vol. 31 (3)
Abstract
Background: The prevalence of malignant central airway obstruction at diagnosis and its 5-year incidence are largely unknown, as are basic epidemiological data pertaining to this serious condition. To address these data limitations, we retrospectively collected data from the cohort of patients diagnosed with lung cancer at our institution in 2015 and followed cohort patients 5 years forward, until 2020. Methods: We reviewed index PET/CT or CT scans at the time of lung cancer diagnosis to identify the presence, subtype, and severity of malignant central airway obstruction as well as progression/development over the next 5 years. Results: The prevalence of malignant central airway obstruction affecting the airway lumen by 25% or greater was 17%, and its 5-year incidence of development was 8.2%. Notable associations from the multivariate analysis included a younger age and a stepwise increase in obstruction with increasing stage of disease. Squamous cell carcinoma and small-cell lung cancer were the 2 histologic subtypes with the strongest association with obstruction. The presence of malignant central airway obstruction either at time of diagnosis or on follow-up imaging was associated with significantly shortened survival (multivariate Cox proportional HR for MCAO=1.702, P<0.001). Conclusion: This study provides the first systematic characterization of fundamental epidemiological data on malignant central airway obstructions at a tertiary cancer center in the United States. This data is important to inform research directions and funding efforts of this serious complication. It also serves as a baseline value against which to compare for future studies.Keywords
This publication has 28 references indexed in Scilit:
- A computational modeling approach for dosing endoscopic intratumoral chemotherapy for advanced non-small cell lung cancerScientific Reports, 2022
- Association of Stage Shift and Population Mortality Among Patients With Non–Small Cell Lung CancerJAMA Network Open, 2021
- The HILUS-Trial—a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body RadiotherapyJournal of Thoracic Oncology, 2021
- Prevalence and outcome of central airway obstruction in patients with lung cancerBMJ Open Respiratory Research, 2019
- Outcome differences between recanalized malignant central airway obstruction from endoluminal disease versus extrinsic compressionLasers in Medical Science, 2018
- Safety and Efficacy of Thoracic External Beam Radiotherapy After Airway Stenting in Malignant Airway ObstructionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Timely Airway Stenting Improves Survival in Patients With Malignant Central Airway ObstructionThe Annals of Thoracic Surgery, 2010
- Central Airway ObstructionAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Interventional Bronchoscopy: 5-Year Experience at the Academic Hospital of the Vrije Universiteit Brussel (AZ-VUB).Acta Clinica Belgica, 1997